Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-26

Clinical Trial Update: Clinical Investigation of the MiStent Drug Eluting Stent (DES) in Coronary Artery Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for the MiStent Drug Eluting Stent in Coronary Artery Disease; the study completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MiStent Drug Eluting Stent

Snippet

Sponsor: Micell Technologies | Conditions: Coronary Artery Disease | Phase 2 | Status: COMPLETED | Results posted: 2014-03-26